New Clinical Data for PROSTASCINT(R) and QUADRAMET(R) in Prostate Cancer Presented at the 2007 Prostate Cancer Symposium (RedNova)
Cytogen Corporation (NASDAQ: CYTO) today report

St. Jude Medical Receives FDA Clearance for Venture Catheter With New Delivery Platform (RedNova)
St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) clearance for the VentureTM Wire Control Catheter on a rapid exchange delivery platform, a delivery design that accommodates shorter guidewires and may result in quicker, easier coronary procedures.

Merck is on the mend (CNN Money)
In the dark autumn of 2004, when Merck withdrew its blockbuster heart drug Vioxx over concerns it caused cardiac arrest, the company lost roughly a third of its market value within days. But in 2006, Merck's shares quietly surged 40%. What's more, there may be enough upside left to this recovery to make the company a solid long-term investment again.